{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:48:48Z","timestamp":1780962528265,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jhin.2022.11.013","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:31:15Z","timestamp":1671535875000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A protracted outbreak of difficult-to-treat resistant Pseudomonas aeruginosa in a haematology unit: a matched case\u2013control study demonstrating increased risk with use of fluoroquinolone"],"prefix":"10.1016","volume":"132","author":[{"given":"W.","family":"Rice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hodgkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barrasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sweeting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2022.11.013_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02494-19","article-title":"Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2022.11.013_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","article-title":"Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome","volume":"88","author":"Tofas","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2022.11.013_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.jhin.2022.11.013_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","article-title":"Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact","volume":"27","author":"Trecarichi","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jhin.2022.11.013_bib6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/cid\/cix132","article-title":"The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections \u2013 a systematic review of the literature","volume":"64","author":"Kizny Gordon","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2022.11.013_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1099\/mic.0.000860","article-title":"Microbe profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat","volume":"166","author":"Diggle","year":"2020","journal-title":"Microbiology"},{"key":"10.1016\/j.jhin.2022.11.013_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2022.11.013_bib9","series-title":"Infectious Diseases Society of America antimicrobial-resistant treatment guidance: Gram-negative bacterial infections","author":"Tamma","year":"2022"},{"key":"10.1016\/j.jhin.2022.11.013_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib11","series-title":"English surveillance programme for antimicrobial utilisation and resistance report","year":"2021"},{"key":"10.1016\/j.jhin.2022.11.013_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jhin.2012.06.007","article-title":"Multidrug-resistant Pseudomonas aeruginosa outbreaks in two hospitals: association with contaminated hospital waste-water systems","volume":"82","author":"Breathnach","year":"2012","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhin.2021.02.001","article-title":"Investigation and control of an outbreak due to a contaminated hospital water system, identified following a rare case of Cupriavidus pauculus bacteraemia","volume":"111","author":"Inkster","year":"2021","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhin.2020.03.034","article-title":"Dissemination of antibiotic resistance and other healthcare waterborne pathogens. The price of poor design, construction, usage and maintenance of modern water\/sanitation services","volume":"105","author":"Weinbren","year":"2020","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhin.2017.07.028","article-title":"Tracking the spread routes of opportunistic premise plumbing pathogens in a haematology unit with water points-of-use protected by antimicrobial filters","volume":"98","author":"Baranovsky","year":"2018","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11908-018-0648-3","article-title":"Sink-related outbreaks and mitigation strategies in healthcare facilities","volume":"20","author":"Parkes","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jhin.2022.11.013_bib17","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhin.2022.11.013_bib18","series-title":"Health Technical Memorandum 04-01: addendum. Pseudomonas aeruginosa \u2013 advice for augmented care units","year":"2013"},{"key":"10.1016\/j.jhin.2022.11.013_bib19","series-title":"Neutropenic sepsis: prevention and management in people with cancer","year":"2012"},{"key":"10.1016\/j.jhin.2022.11.013_bib20","series-title":"Exceptional surveillance of neutropenic sepsis: prevention and management in people with cancer","year":"2020"},{"key":"10.1016\/j.jhin.2022.11.013_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","article-title":"Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"7","author":"Raman","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jhin.2022.11.013_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s15010-014-0635-z","article-title":"Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections","volume":"42","author":"Samonis","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.jhin.2022.11.013_bib23","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/cid\/ciy825","article-title":"Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients","volume":"68","author":"Hakki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2022.11.013_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/ice.2017.304","article-title":"A\u00a0bundle of measures to control an outbreak of Pseudomonas aeruginosa associated with P-trap contamination","volume":"39","author":"Gbaguidi-Haore","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2022.11.013_bib25","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhin.2022.11.013_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmi.2019.07.002","article-title":"Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection","volume":"26","author":"Viasus","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199531","article-title":"Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance","volume":"13","author":"Garcia-Vidal","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2022.11.013_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13186","article-title":"Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: results from a multicentric surveillance cohort study","volume":"21","author":"Kern","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhin.2022.11.013_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12879-017-2597-0","article-title":"Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2022.11.013_bib30","doi-asserted-by":"crossref","first-page":"501e1","DOI":"10.1016\/j.jtct.2021.03.017","article-title":"Risk factors for mortality in hematopoietic stem cell transplantation recipients with bloodstream infection: points to be addressed by future guidelines","volume":"27","author":"Puerta-Alcalde","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jhin.2022.11.013_bib31","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jhin.2022.11.013_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cmi.2017.11.019","article-title":"Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before\u2013after study","volume":"24","author":"Yeshurun","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2022.11.013_bib33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmi.2018.02.031","article-title":"Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?","volume":"24","author":"Mikulska","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019567012200367X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019567012200367X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:21:41Z","timestamp":1759292501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019567012200367X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"alternative-id":["S019567012200367X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2022.11.013","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A protracted outbreak of difficult-to-treat resistant Pseudomonas aeruginosa in a haematology unit: a matched case\u2013control study demonstrating increased risk with use of fluoroquinolone","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2022.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}